Great Diamond Partners, LLC Astrazeneca PLC Transaction History

Great Diamond Partners, LLC

$387 Million
Q3 2024

A detailed history of Great Diamond Partners, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Great Diamond Partners, LLC holds 4,871 shares of AZN stock, worth $319,683. This represents 0.1% of its overall portfolio holdings.

Number of Shares

4,871

Previous 6,362 23.44%

Holding current value

$319,683

Previous $496,000 23.59%

% of portfolio

0.1%

Previous 0.12%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 25, 2024	SELL	$76.67 - $87.62 $114,314 - $130,641	-1,491 Reduced 23.44%	4,871 $379,000
Q2 2024 Jul 29, 2024	SELL	$66.81 - $80.83 $30,732 - $37,181	-460 Reduced 6.74%	6,362 $496,000
Q1 2024 May 08, 2024	SELL	$61.03 - $69.57 $12,206 - $13,913	-200 Reduced 2.85%	6,822 $462,000
Q4 2023 Feb 07, 2024	SELL	$61.89 - $69.28 $40,847 - $45,724	-660 Reduced 8.59%	7,022 $472,000
Q3 2023 Oct 19, 2023	SELL	$64.85 - $71.7 $39,558 - $43,737	-610 Reduced 7.36%	7,682 $520,000
Q2 2023 Jul 17, 2023	SELL	$69.91 - $75.81 $7,410 - $8,035	-106 Reduced 1.26%	8,292 $593,000
Q1 2023 May 04, 2023	BUY	$63.15 - $71.6 $4,231 - $4,797	67 Added 0.8%	8,398 $582,000
Q4 2022 Feb 01, 2023	SELL	$54.21 - $70.44 $1,192 - $1,549	-22 Reduced 0.26%	8,331 $564,000
Q3 2022 Oct 24, 2022	BUY	$53.02 - $135.75 $5,832 - $14,932	110 Added 1.33%	8,353 $458,000
Q2 2022 Jul 26, 2022	BUY	$59.26 - $71.14 $111,586 - $133,956	1,883 Added 29.61%	8,243 $544,000
Q1 2022 May 05, 2022	BUY	$55.72 - $67.12 $57,670 - $69,469	1,035 Added 19.44%	6,360 $421,000
Q4 2021 Jan 26, 2022	BUY	$54.02 - $63.83 $26,199 - $30,957	485 Added 10.02%	5,325 $310,000
Q3 2021 Oct 21, 2021	BUY	$55.56 - $60.79 $5,944 - $6,504	107 Added 2.26%	4,840 $290,000
Q2 2021 Jul 26, 2021	BUY	$48.42 - $60.18 $13,702 - $17,030	283 Added 6.36%	4,733 $283,000
Q1 2021 May 04, 2021	BUY	$47.16 - $54.44 $9,432 - $10,888	200 Added 4.71%	4,450 $221,000
Q4 2020 Jan 26, 2021	SELL	$48.52 - $58.02 $74,381 - $88,944	-1,533 Reduced 26.51%	4,250 $212,000
Q3 2020 Oct 19, 2020	SELL	$53.07 - $61.1 $18,680 - $21,507	-352 Reduced 5.74%	5,783 $316,000
Q2 2020 Aug 04, 2020	SELL	$43.1 - $55.31 $6,637 - $8,517	-154 Reduced 2.45%	6,135 $324,000
Q1 2020 May 01, 2020	BUY	$37.79 - $51.33 $146,511 - $199,006	3,877 Added 160.74%	6,289 $280,000
Q4 2019 Feb 07, 2020	BUY	$42.46 - $50.46 $102,413 - $121,709	2,412 New	2,412 $120,000

Others Institutions Holding AZN

# of Institutions

1,359

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $203B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Diamond Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Great Diamond Partners, LLC with notifications on news.

Account

Great Diamond Partners, LLC Astrazeneca PLC Transaction History